Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy ZIOP NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


ZIOPHARM Oncology (ZIOP)

@ 4:00 PM
Click the portfolio to add ZIOP:
Close [X]
+ Add ZIOP to Portfolio
  
  Last Trade: $5.32 -0.13 (-2.39%)
  Volume: 452,930 59% of avg daily volume
       
  Avg Volume: 765,812
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 5.30 - 5.54
  Open: 5.45
  Previous Close: 5.45
  52-wk Range: 3.55 - 7.85
  Market Cap: 386.7M
  P/E: -5.5
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy ZIOP

? Pro holders
? Member holders
? Items submitted
Additional ZIOP resources



Customize Links
To see which Pros and tickerspy members own ZIOP Sign up now
Latest ZIOP Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

ZIOPHARM Oncology to Present at the 14th Annual BIO CEO & Investor Conference
ZIOP  
Linked by GlobeNewswire - February 07, 06:10AM from (www.globenewswire.com)
NEW YORK, Feb. 7, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D.,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZIOPHARM Announces FDA Acceptance of IND for Oral Palifosfamide
ZIOP  
Linked by GlobeNewswire - February 06, 06:10AM from (www.globenewswire.com)
NEW YORK, Feb. 6, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company with small  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma
ZIOP  
Linked by GlobeNewswire - January 30, 06:10AM from (www.globenewswire.com)
NEW YORK, Jan. 30, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company with small  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Secondary Stock Offering Floodgates Open Wide
NAT  SQNM  ZIOP  AONE  MMLP  HTGC  ARCC  BWP  SAVE  FRAN  
Linked by 24/7 Wall St. - January 20, 11:50AM from (247wallst.com)
If you watch underwritings in stocks, it would be literally impossible not to pay attention to the waves of secondary stock  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZIOPHARM Oncology Prices Public Offering of Common Stock
ZIOP  
Linked by GlobeNewswire - January 20, 09:28AM from (www.globenewswire.com)
NEW YORK, Jan. 20, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced the pricing of an underwritten  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
ZIOP  
Linked by GlobeNewswire - January 19, 04:05PM from (www.globenewswire.com)
NEW YORK, Jan. 19, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that it intends to commence  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Should Biotech Investors Go Where Institutions Won't?
NAVB  MNKD  ALXN  MELA  ZIOP  ONTY  
Linked by Investopedia Stock Analysis - July 07, 10:30AM from (stocks.investopedia.com)
A lack of institutional ownership should be a warning sign for biotech investors.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Insiders Snapping Up Ziopharm Oncology, Schulman and More
ZIOP  
Linked by BloggingStocks - January 25, 11:00AM from (www.bloggingstocks.com)
If you are looking for clues telling you which stocks have a good chance of increasing in value, you might want consider  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
ZIOP  
Linked by BusinessWire - November 08, 08:35AM from (www.businesswire.com)
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has appointed Brian L. Hamilton, M.D., Ph.D., as Senior Vice  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource